Literature DB >> 34374834

Influenza and prophylactic antifungal therapy for aspergillosis: addressing some questions first.

Anne Coste1, Kahaia De Longeaux2, Cécile Aubron3,4.   

Abstract

Entities:  

Year:  2021        PMID： 34374834     DOI： 10.1007/s00134-021-06488-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Increased incidence of co-infection in critically ill patients with influenza.

Authors:  Ignacio Martin-Loeches; Marcus J Schultz; Jean-Louis Vincent; Francisco Alvarez-Lerma; Lieuwe D Bos; Jordi Solé-Violán; Antoni Torres; Alejandro Rodriguez
Journal:  Intensive Care Med       Date:  2016-10-05       Impact factor: 17.440

2.  The Extent of Aspergillosis in Critically Ill Patients With Severe Influenza Pneumonia: A Multicenter Cohort Study.

Authors:  Anne Coste; Aurélien Frérou; Anaïs Raute; Francis Couturaud; Jean Morin; Pierre-Yves Egreteau; François-Xavier Blanc; Jean Reignier; Jean-Marc Tadié; Adissa Tran; Charlotte Pronier; Marianne Coste-Burel; Gilles Nevez; Jean-Pierre Gangneux; Patrice Le Pape; Séverine Ansart; Jean-Marie Tonnelier; Cédric Bretonnière; Cécile Aubron
Journal:  Crit Care Med       Date:  2021-06-01       Impact factor: 7.598

Review 3.  Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis.

Authors:  M Bassetti; D R Giacobbe; C Grecchi; C Rebuffi; V Zuccaro; L Scudeller
Journal:  J Infect       Date:  2020-04-21       Impact factor: 6.072

4.  Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.

Authors:  Paul E Verweij; Bart J A Rijnders; Roger J M Brüggemann; Elie Azoulay; Matteo Bassetti; Stijn Blot; Thierry Calandra; Cornelius J Clancy; Oliver A Cornely; Tom Chiller; Pieter Depuydt; Daniele Roberto Giacobbe; Nico A F Janssen; Bart-Jan Kullberg; Katrien Lagrou; Cornelia Lass-Flörl; Russell E Lewis; Peter Wei-Lun Liu; Olivier Lortholary; Johan Maertens; Ignacio Martin-Loeches; M Hong Nguyen; Thomas F Patterson; Thomas R Rogers; Jeroen A Schouten; Isabel Spriet; Lore Vanderbeke; Joost Wauters; Frank L van de Veerdonk
Journal:  Intensive Care Med       Date:  2020-06-22       Impact factor: 17.440

5.  Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.

Authors:  Lore Vanderbeke; Nico A F Janssen; Roger J M Brüggemann; Joost Wauters; Dennis C J J Bergmans; Marc Bourgeois; Jochem B Buil; Yves Debaveye; Pieter Depuydt; Simon Feys; Greet Hermans; Oscar Hoiting; Ben van der Hoven; Cato Jacobs; Katrien Lagrou; Virginie Lemiale; Piet Lormans; Johan Maertens; Philippe Meersseman; Bruno Mégarbane; Saad Nseir; Jos A H van Oers; Marijke Reynders; Bart J A Rijnders; Jeroen A Schouten; Isabel Spriet; Karin Thevissen; Arnaud W Thille; Ruth Van Daele; Frank L van de Veerdonk; Paul E Verweij; Alexander Wilmer
Journal:  Intensive Care Med       Date:  2021-05-29       Impact factor: 17.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.